Evidence map›Paper›PMID 37868701›Full record

ArticleInfection and drug resistance2023

Resistance Transition of

Jin Xia, Lan Lu, Ke-Lei Zhao, Qiang-Lin Zeng

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jin XiaDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital/Clinical College of Chengdu University, Chengdu, Sichuan, 610081, People's Republic of China.
Lan LuAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, Sichuan, 610106, People's Republic of China.
Ke-Lei ZhaoAntibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, Sichuan, 610106, People's Republic of China.
Qiang-Lin ZengDepartment of Respiratory and Critical Care Medicine, Affiliated Hospital/Clinical College of Chengdu University, Chengdu, Sichuan, 610081, People's Republic of China.
Chengdu University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the impact of coronavirus disease 2019 (COVID-19) specified preventive and control measures on the distribution and resistance transition of Methods: This retrospective study retrieved data from 316 Results: Compared with the pre-pandemic year, the isolation rate of Conclusion: The COVID-19 specified preventive and control measures have influenced the distribution and resistance transition of

Indexed as

COVID-19drug resistanceisolation ratePseudomonas aeruginosa

Identifiers

PMID37868701
PMCPMC10588708
OpenAlexW4387650210

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.